Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General
  • Legal
  • News
  • Politics

SEC Says Has Added Global Cord Blood Corporation To Provisional List Of Issuers Identified Under Holding Foreign Companies Accountable Act

By Benzinga Newsdesk
August 22, 1:25 PM
-Reuters

CO

Read More
1 minute read
  • General
  • Legal
  • News
  • Politics

SEC Says Has Added Mogu Inc, Cheetah Mobile, Alibaba Group Holding, Boqii Holding Limited In Its Conclusive List Of Issuers Identified Under Holding Foreign Companies Accountable Act

By Benzinga Newsdesk
August 22, 1:22 PM
-Reuters

BABA

Read More
1 minute read
  • General
  • News
  • Politics

U.S. Warned Russian Ambassador To Washington Last Week Against Escalation Of War In Ukraine, Called On Russia To Cease Military Operations At Or Near Zaporizhzhia Nuclear Plant

By Benzinga Newsdesk
August 22, 11:48 AM
-Reuters

RSX

Read More
1 minute read
  • General
  • M&A
  • News
  • Penny Stocks

Phoenix Motor Acquires Hydrogen Cell Assets From Altergy Systems

By Shivani Kumaresan
August 22, 11:42 AM
Phoenix Motor Inc (NASDAQ:PEV) has acquired hydrogen fuel cell manufacturing assets from Altergy Systems. The details of the transaction were not disclosed.…

PEV

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Penny Stocks

Kronos Bio Shares Fall After Initial-Stage Blood Cancer Study Takes-off

By Ragothaman Srinivasan
August 22, 11:39 AM
Kronos Bio (NASDAQ: KRON) has initiated patient dosing in a Phase 1b/2 clinical trial of lanraplenib in combination with gilteritinib in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia (AML).

KRON

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Minerva Seeks FDA Approval For Its Schizophrenia Candidate

By Vandana Singh
August 22, 11:38 AM
Minerva Neurosciences Inc (NASDAQ:NERV) submitted a marketing application to the FDA for roluperidone for negative symptoms in patients with schizophrenia.  “We…

NERV

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Boosters Are Coming For Dangerous Omicron COVID-19 Variant. Here’s Who May Be Rolling Them Out

By Vandana Singh
August 22, 11:36 AM
Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have completed a submission to the FDA requesting Emergency Use Authorization for an omicron BA.4/BA.5-adapted COVID-19…

BNTX

Read More
1 minute read
  • Biotech
  • General
  • Government
  • Health Care
  • News
  • Top Stories

Dr. Anthony Fauci, Face Of US COVID-19 Response, To Retire In December

By Vandana Singh
August 22, 11:30 AM
 

AZN

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Belite Bio Starts Enrollment In Pivotal Lead Asset Study In Inherited Eye Disease

By Vandana Singh
August 22, 11:27 AM
Belite Bio Inc (NASDAQ:BLTE) commenced enrollment for the U.S. Phase 3 trial of LBS-008 in patients with Stargardt Disease (STGD1), a…

BLTE

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Gilead’s Lenacapavir Scores European Approval For Pretreated HIV Patients After Manufacturing Delays

By Vandana Singh
August 22, 11:25 AM
The European Commission has approved Gilead Sciences Inc’s (NASDAQ:GILD) lenacapavir for adults with multi-drug resistant HIV infection.  The drug, branded as…

GILD

Posts pagination

Previous 1 … 2,209 2,210 2,211 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service